OssDsign AB (OSTO:OSSD) ROC (Joel Greenblatt) %: -250.38% (As of Mar. 2026)


OSTO:OSSD OssDsign AB OSTO:OSSD
58 GF Score
Price kr4.11
GF Value kr11.13
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is OssDsign AB ROC (Joel Greenblatt) %?

OssDsign AB OSTO:OSSD +4.05% 58 ROC (Joel Greenblatt) % is -250.38% as of Mar. 2026. GuruFocus rates OSTO:OSSD with a GF Score™ of 58/100 and a GF Value™ of kr11.13 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 839 Medical Devices & Instruments companies, OssDsign AB ranks worse than 80.57% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. OssDsign AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -250.38%.

The historical rank and industry rank for OssDsign AB's ROC (Joel Greenblatt) % or its related term are showing as below:

OSTO:OSSD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -2018.02   Med: -749.31   Max: -190.62
Current: -190.62

During the past 9 years, OssDsign AB's highest ROC (Joel Greenblatt) % was -190.62%. The lowest was -2018.02%. And the median was -749.31%.

OSTO:OSSD's ROC (Joel Greenblatt) % is ranked worse than
80.57% of 839 companies
in the Medical Devices & Instruments industry
Industry Median: 3.94 vs OSTO:OSSD: -190.62

OssDsign AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 5.40% per year.


OssDsign AB  (OSTO:OSSD) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


OssDsign AB ROC (Joel Greenblatt) % Related Terms


OssDsign AB ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for OssDsign AB's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OssDsign AB ROC (Joel Greenblatt) % Chart

OssDsign AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only -554.30 -647.07 -1,587.12 -749.31 -368.33

OssDsign AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -310.71 -110.89 -75.45 -353.02 -250.38

OSTO:OSSD vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison

For the Medical Devices subindustry, OssDsign AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OssDsign AB ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OssDsign AB's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where OssDsign AB's ROC (Joel Greenblatt) % falls into.


OSTO:OSSD
58GF Score
OssDsign AB OSTO:OSSD
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OssDsign AB ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(26.131 + 22.678 + 0.91300000000001) - (5.375 + 0 + 28.924)
=15.423

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(21.739 + 21.14 + 6.593) - (6.469 + 0 + 18.989)
=24.014

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of OssDsign AB for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-53.86/( ( (1.906 + max(15.423, 0)) + (1.679 + max(24.014, 0)) )/ 2 )
=-53.86/( ( 17.329 + 25.693 )/ 2 )
=-53.86/21.511
=-250.38 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -250.38% mean?
OssDsign AB (OSTO:OSSD) has a ROC (Joel Greenblatt) % of -250.38% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on OssDsign AB and its competitors. According to the industry distribution chart, OssDsign AB ranks #676 out of 839 companies in the Medical Devices & Instruments industry, placing it in the top 80.6%.
Is OssDsign AB's ROC (Joel Greenblatt) % too high?
OssDsign AB's current ROC (Joel Greenblatt) % is -250.38%. Based on the distribution chart, OssDsign AB ranks #676 out of 839 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, OssDsign AB has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OssDsign AB's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, OssDsign AB ranks #676 out of 839 companies for ROC (Joel Greenblatt) %. This places OssDsign AB in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 3.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 3.94, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on OssDsign AB and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 3.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OssDsign AB's current ROC (Joel Greenblatt) % is -250.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OssDsign AB stock overvalued right now?
Based on GuruFocus' analysis, OssDsign AB (OSTO:OSSD) is currently considered Possible Value Trap. The stock's GF Value™ is kr11.13, compared to a current price of kr4.11 — trading 63.1% below its estimated fair value. The current ROC (Joel Greenblatt) % is -250.38%. OssDsign AB's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For OssDsign AB (OSTO:OSSD), the current ROC (Joel Greenblatt) % is -250.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OssDsign AB (OSTO:OSSD) Overvalued in 2026?

Based on GuruFocus' analysis, OssDsign AB stock appears to be undervalued. The current stock price of kr4.11 is trading 63.1% below its estimated GF Value™ of kr11.13. GuruFocus considers OssDsign AB to be Possible Value Trap.

Key valuation signals for OSTO:OSSD:

  • ROC (Joel Greenblatt) %: -250.38%
  • GF Value™: kr11.13 vs. price of kr4.11 (63.1% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the OSTO:OSSD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OssDsign AB Business Description

Other Exchanges 5J6:Germany
Address Ulls vag 29C, Uppsala, SWE, 75651
OssDsign AB is a developer and international provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the USA, Germany, Sweden and UK. The company generates the majority of its revenue from the USA region.
58GF Score

Get the complete analysis for OSTO:OSSD

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.11
Price
kr11.13
GF Value